The 27 references in paper О. Kapuler M., Е. Nelyubin V., D. Kaut A., S. Sibiryak V., О. Капулер М., Е. Нелюбин В., Д. Каут А., С. Сибиряк В. (2014) “АПОПТОЗ ЛИМФОЦИТОВ ПРИ ПСОРИАЗЕ // LYMPHOCYTE APOPTOSIS IN PSORIASIS” / spz:neicon:mimmun:y:2006:i:4:p:531-538

1
Казанцева И. А. Апоптоз и его роль в патологии кожи // Российский журнал кожных и венерических болезней - 2000. - No4. - С. 17-22.
(check this in PDF content)
2
Капулер О.М., Каут Д.А., Сибиряк С.В. Субпопуляционная структура лимфоцитов при псориазе // Иммунология Урала (Материалы IV конф. Иммунологов Урала). - 2005. - No 1(4) - С. 61-62.
(check this in PDF content)
3
Ковальчук Л.В., Чередеев А.Н. Новые иммунопатогенетические взгляды: апоптотические иммунодефициты // Иммунология. - 1998. - No 6. - С. 17-18.
(check this in PDF content)
4
Кунгуров Н.В., Филимонкова Н.Н., Тузанкина И.А. Псориатическая болезнь. - Екатеринбург: Изд-во Урал. Ун-та, 2002. - 200 с.
(check this in PDF content)
5
Новиков А.И., Кононов А.В., Охлопков В.А., Правдина О.В. и др. Иммунохимические исследования при псориазе // Вестн. дерматол. венерол.2003. - No 3. - C. 26-28.
(check this in PDF content)
6
Ярилин А.А. Апоптоз и его место в иммунных процессах // Иммунология. - 1996. - No 6. - С. 10 - 23.
(check this in PDF content)
7
Arnold R., Seifert M., Asadullah Kh., Dieter H. et al. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand Interaction: Modulation by Cytokines processes // J. Immunol. - 1999. - Vol. 162. - P.7140 - 7147.
(check this in PDF content)
8
Budd R. Death receptors couple both cell proliferation and apoptosis // J. Clin. Invest. - 2002. - Vol. 109. - P.437-450.
(check this in PDF content)
9
Cheng J., Zhou T., Liu C., Shapiro J. et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule // Science - 1994. - Vol. 263. - P. 1759-1762.
(check this in PDF content)
10
Christensson M., Pettersson E., Eneslatt K. et al. Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases // J. Clin Immunol. - 2002.- Vol. 22. - P. 220-227.
(check this in PDF content)
11
Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content // Meth. Cell Biol. - 1994. - Vol. 41. - P. 401-420.
(check this in PDF content)
12
Gladman D. Discussion: Clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis // Ann. Rheum. Dis.2005. - Vol.64. - P.24-25.
(check this in PDF content)
13
Hildeman D., Mitchell Th., Kappler J., Marrack Ph. T cell apoptosis and reactive oxygen species // J. Clin. Invest. - 2003. - Vol. 111. - P. 575-581.
(check this in PDF content)
14
Knipping E., Krammer P., Onel K. et al. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis // Arthritis Rheum. - 1995. - Vol. 38. - P. 1735-1737.
(check this in PDF content)
15
Koopman G., Reuterlingsperger C., Kiijten G., Keehnen R. et al. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis // Blood. - 1994. - Vol. 84. - P. 1415 - 1420.
(check this in PDF content)
16
Krammer P. CD95’s deadly mission in the immune system // Nature. - 2000. - Vol. 407. - P. 789 - 795.
(check this in PDF content)
17
Lahdenpohja N., Naive H. (CD45RA+) T lymphocytes are more sensitive to oxidative stress-induced signals than memory (CD45RO+) cells // Cell Immunol. - 1996. - Vol. 173. - P. 282-286.
(check this in PDF content)
18
Lecewicz-Torun B., Pietrzak A., Rolinski J., Brzozowski W. The peripheral blood lymphocyte pattern in psoriasis proceeded by an infection // Med. Sci. Monit. - 2001. - Vol.7. - P. 889-893.
(check this in PDF content)
19
Lorenz H., Grunke M., Hieronymus T. et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases // Arthritis Rheum. - 1997 . - Vol. 40. - P. 306-317.
(check this in PDF content)
20
Nickoloff B., Nestle O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities // J. Clin. Invest. - 2004. - Vol. 113.P.1664-1675.
(check this in PDF content)
21
Nozawa K., Kayagaki N., Tokano Y. Et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases // Arthritis Rheum. - 1997. - Vol. 40.P. 1126-1129.
(check this in PDF content)
22
Papoff G., Cascino I., Eramo A. et al. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro // J. Immunol.1996. - Vol. 156. - P. 4622-4630.
(check this in PDF content)
23
Seishima M., Seishima M., Takemura M., Saito K. et al. Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis // Dermatology.- 1998. - Vol. 196. - P.371-372.
(check this in PDF content)
24
Linden M., T Van Lopik T., L A Aarden L. et al. Soluble CD95 concentrations are increased in patients with severe systemic lupus erythematosus, but not in their first degree relatives //Ann. Rheum. Dis.Vol. 2001. - Vol. 60. - P. 237-241.
(check this in PDF content)
25
Vissers W., Arndtz C., Muys L., Van Erp P. et al. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late // Br. J. Dermatol. - 2004. - Vol. 150. - P. 852-859.
(check this in PDF content)
26
Wrone-Smith T., Johnson T., Nelson B., Boise L. et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo // Amer. J. Pathol. - 1995. - Vol. 146. - P.1079 -1088.
(check this in PDF content)
27
Zhuang Sh, Demirs J., Kochevar I. p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide // J. Biol. Chem. - 2000. - Vol. 275. - P. 25939-25948.
(check this in PDF content)